Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Apply
DPX-Survivac & Pembrolizumab
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step